Banco do Brasil S.A. (BVMF:BBAS3)

Orchard Therapeutics Income Statement

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest Income on Loans	166,038	160,973	138,068	121,010	86,960	87,190
Interest Income on Investments	127,380	127,380	129,056	119,244	44,547	30,666
Total Interest Income	293,418	288,353	267,123	240,255	131,507	117,856
Interest Paid on Deposits	64,108	57,112	66,276	54,176	21,116	15,103
Interest Paid on Borrowings	125,598	125,598	104,591	105,675	47,036	51,376
Total Interest Expense	189,706	182,711	170,868	159,851	68,152	66,479
Net Interest Income	103,712	105,643	96,256	80,404	63,355	51,378
Net Interest Income Growth (YoY)	1.45%	9.75%	19.71%	26.91%	23.31%	-3.01%
Gain (Loss) on Sale of Assets	-27.72	-	-	-	-	-
Gain (Loss) on Sale of Investments	-1,878	-1,878	2,791	1,395	-505.46	556.85
Other Non-Interest Income	44,078	39,931	32,712	31,750	30,746	32,109
Total Non-Interest Income	41,868	38,053	35,503	33,145	30,241	32,666
Non-Interest Income Growth (YoY)	11.80%	7.18%	7.11%	9.61%	-7.42%	3.84%
Revenues Before Loan Losses	145,580	143,696	131,759	113,549	93,595	84,044
Provision for Loan Losses	53,058	41,422	32,221	23,547	17,884	25,561
Revenue	92,522	102,274	99,538	90,002	75,711	58,483
Revenue Growth (YoY)	-10.94%	2.75%	10.60%	18.88%	29.46%	-5.28%
Salaries and Employee Benefits	29,000	28,844	27,457	25,531	23,535	21,720
Selling, General & Administrative	14,655	14,570	14,196	12,974	12,848	13,064
Other Non-Interest Expense	11,120	12,573	12,175	6,452	8,853	9,894
Total Non-Interest Expense	46,900	47,925	46,250	38,515	41,744	41,412
EBT Excluding Unusual Items	45,622	54,349	53,288	51,488	33,968	17,071
Legal Settlements	-12,055	-11,634	-8,335	-8,029	-7,768	-4,066
Other Unusual Items	-247.12	-247.12	-390.53	-281.32	-442.07	-183.59
Pretax Income	33,320	42,468	44,563	43,178	25,757	12,821
Income Tax Expense	-1,274	3,372	6,956	9,383	4,441	-1,453
Earnings From Continuing Operations	34,593	39,096	37,607	33,795	21,316	14,274
Minority Interest in Earnings	-3,744	-3,656	-3,788	-2,683	-1,606	-1,577
Net Income	30,849	35,440	33,819	31,112	19,710	12,697
Preferred Dividends & Other Adjustments	-	-	-	-	-	185.23
Net Income to Common	30,849	35,440	33,819	31,112	19,710	12,512
Net Income Growth	-8.30%	4.79%	8.70%	57.85%	55.23%	-30.09%
Basic Shares Outstanding	5,709	5,708	5,708	5,708	5,707	5,705
Diluted Shares Outstanding	5,709	5,708	5,708	5,708	5,707	5,705
Shares Change (YoY)	0.01%	0.01%	0.01%	0.01%	0.04%	1.90%
EPS (Basic)	5.40	6.21	5.92	5.45	3.45	2.19
EPS (Diluted)	5.40	6.21	5.92	5.45	3.45	2.19
EPS Growth	-8.31%	4.79%	8.69%	57.84%	57.47%	-31.40%
Dividend Per Share	2.478	2.863	2.283	2.069	1.319	0.736
Dividend Growth	-4.20%	25.41%	10.34%	56.80%	79.28%	-38.69%
Effective Tax Rate	-	7.94%	15.61%	21.73%	17.24%	-

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.